Advertisement

More articles from Chemical Therapeutics

  • Microtubule Inhibitor Destabilizes HIF-1α mRNA
    Yun-Ching Cheng, Jing-Ping Liou, Ching-Chuan Kuo, Wen-Yang Lai, Kuang-Hsing Shih, Chi-Yen Chang, Wen-Yu Pan, Joseph T. Tseng, Jang-Yang Chang
    Molecular Cancer Therapeutics Jul 2013, 12 (7) 1202-1212; DOI: 10.1158/1535-7163.MCT-12-0778
  • CRM1/BRAF Inhibition in Melanoma
    Roberto A. Salas Fragomeni, Hye Won Chung, Yosef Landesman, William Senapedis, Jean-Richard Saint-Martin, Hensin Tsao, Keith T. Flaherty, Sharon Shacham, Michael Kauffman, James C. Cusack
    Molecular Cancer Therapeutics Jul 2013, 12 (7) 1171-1179; DOI: 10.1158/1535-7163.MCT-12-1171
  • SEN461 Inhibits Canonical Wnt Signaling and Glioblastoma Growth
    Alessandra De Robertis, Silvia Valensin, Marco Rossi, Patrizia Tunici, Margherita Verani, Antonella De Rosa, Cinzia Giordano, Maurizio Varrone, Arianna Nencini, Carmela Pratelli, Tiziana Benicchi, Annette Bakker, Jeffrey Hill, Kanda Sangthongpitag, Vishal Pendharkar, Boping Liu, Fui Mee Ng, Siew Wen Then, Shi Jing Tai, Seong-Moon Cheong, Xi He, Andrea Caricasole, Massimiliano Salerno
    Molecular Cancer Therapeutics Jul 2013, 12 (7) 1180-1189; DOI: 10.1158/1535-7163.MCT-12-1176-T
  • CXCR4-Targeted Therapy for Chondrosarcoma
    Xiaojuan Sun, Cherie Charbonneau, Lei Wei, Wentian Yang, Qian Chen, Richard M. Terek
    Molecular Cancer Therapeutics Jul 2013, 12 (7) 1163-1170; DOI: 10.1158/1535-7163.MCT-12-1092
  • PG545 Reduces Pancreatic Tumor Progression
    Katherine T. Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, Stefan Hinz, Keith Dredge, Roderich E. Schwarz, Rolf A. Brekken
    Molecular Cancer Therapeutics Jul 2013, 12 (7) 1190-1201; DOI: 10.1158/1535-7163.MCT-12-1123
  • Preclinical Evaluation of ATM Inhibitor, KU59403
    Michael A. Batey, Yan Zhao, Suzanne Kyle, Caroline Richardson, Andrew Slade, Niall M.B. Martin, Alan Lau, David R. Newell, Nicola J. Curtin
    Molecular Cancer Therapeutics Jun 2013, 12 (6) 959-967; DOI: 10.1158/1535-7163.MCT-12-0707
  • Antileukemia Effects of Chk1/HDAC Inhibitors
    Yun Dai, Shuang Chen, Maciej Kmieciak, Liang Zhou, Hui Lin, Xin-Yan Pei, Steven Grant
    Molecular Cancer Therapeutics Jun 2013, 12 (6) 878-889; DOI: 10.1158/1535-7163.MCT-12-0902
  • A Small-Molecule gp130 Inhibitor for Ovarian Cancer Treatment
    Shili Xu, Fedora Grande, Antonio Garofalo, Nouri Neamati
    Molecular Cancer Therapeutics Jun 2013, 12 (6) 937-949; DOI: 10.1158/1535-7163.MCT-12-1082
  • Multitarget Inhibitor in Drug Resistance Treatment
    Jing Wang, Natalie W. Pursell, Maria Elena S. Samson, Ruzanna Atoyan, Anna W. Ma, Abdelkader Selmi, Wanlu Xu, Xiong Cai, Maurizio Voi, Pierre Savagner, Cheng-Jung Lai
    Molecular Cancer Therapeutics Jun 2013, 12 (6) 925-936; DOI: 10.1158/1535-7163.MCT-12-1045
  • HSP90 Inhibition in NSCLC
    Edward B. Garon, Richard S. Finn, Habib Hamidi, Judy Dering, Sharon Pitts, Naeimeh Kamranpour, Amrita J. Desai, Wylie Hosmer, Susan Ide, Emin Avsar, Michael Rugaard Jensen, Cornelia Quadt, Manway Liu, Steven M. Dubinett, Dennis J. Slamon
    Molecular Cancer Therapeutics Jun 2013, 12 (6) 890-900; DOI: 10.1158/1535-7163.MCT-12-0998

Pages